Travis Nemkov
Concepts (631)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Erythrocytes | 56 | 2026 | 749 | 8.060 |
Why?
| | Blood Preservation | 31 | 2026 | 346 | 4.510 |
Why?
| | Metabolomics | 35 | 2026 | 737 | 3.980 |
Why?
| | Metabolome | 25 | 2026 | 390 | 2.810 |
Why?
| | Hemolysis | 13 | 2025 | 242 | 2.610 |
Why?
| | Glycolysis | 23 | 2025 | 341 | 2.270 |
Why?
| | Blood Donors | 11 | 2025 | 145 | 2.240 |
Why?
| | High-Throughput Screening Assays | 5 | 2026 | 179 | 1.970 |
Why?
| | Erythrocyte Transfusion | 14 | 2026 | 225 | 1.550 |
Why?
| | Drosophila melanogaster | 11 | 2025 | 237 | 1.480 |
Why?
| | Mass Spectrometry | 12 | 2026 | 728 | 1.440 |
Why?
| | Transfusion Medicine | 2 | 2026 | 20 | 1.360 |
Why?
| | Drosophila Proteins | 10 | 2025 | 207 | 1.350 |
Why?
| | Carnitine | 4 | 2024 | 91 | 1.030 |
Why?
| | Hypoxia | 11 | 2024 | 1209 | 0.970 |
Why?
| | Energy Metabolism | 11 | 2024 | 930 | 0.930 |
Why?
| | Oxidative Stress | 15 | 2025 | 1367 | 0.910 |
Why?
| | Amino Acids | 10 | 2023 | 513 | 0.900 |
Why?
| | Animals | 78 | 2026 | 38030 | 0.850 |
Why?
| | Membrane Lipids | 2 | 2021 | 81 | 0.780 |
Why?
| | Hematopoietic Stem Cells | 5 | 2026 | 432 | 0.780 |
Why?
| | Mice | 45 | 2026 | 18266 | 0.780 |
Why?
| | Hemoglobins | 6 | 2025 | 384 | 0.770 |
Why?
| | Proteomics | 8 | 2025 | 1202 | 0.740 |
Why?
| | Shock, Hemorrhagic | 7 | 2020 | 195 | 0.740 |
Why?
| | Erythroblasts | 1 | 2022 | 18 | 0.720 |
Why?
| | Blood Platelets | 5 | 2025 | 380 | 0.710 |
Why?
| | Athletic Performance | 1 | 2023 | 78 | 0.690 |
Why?
| | Glucosephosphate Dehydrogenase Deficiency | 4 | 2025 | 34 | 0.690 |
Why?
| | Purines | 4 | 2022 | 188 | 0.660 |
Why?
| | Lipid Metabolism | 6 | 2021 | 533 | 0.650 |
Why?
| | Nonprescription Drugs | 1 | 2021 | 68 | 0.630 |
Why?
| | Receptor, Adenosine A2B | 4 | 2025 | 65 | 0.620 |
Why?
| | Humans | 109 | 2026 | 145625 | 0.620 |
Why?
| | Physical Exertion | 1 | 2021 | 204 | 0.600 |
Why?
| | Leukemia | 2 | 2019 | 246 | 0.590 |
Why?
| | Glucosephosphate Dehydrogenase | 4 | 2025 | 70 | 0.590 |
Why?
| | Prescription Drugs | 1 | 2021 | 110 | 0.590 |
Why?
| | Carbon | 2 | 2017 | 176 | 0.570 |
Why?
| | Fatty Acids | 7 | 2024 | 460 | 0.560 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2025 | 299 | 0.560 |
Why?
| | Lymph | 2 | 2016 | 31 | 0.550 |
Why?
| | Iron | 3 | 2025 | 359 | 0.550 |
Why?
| | Cell Death | 1 | 2020 | 379 | 0.540 |
Why?
| | Hypoxanthine | 1 | 2017 | 11 | 0.530 |
Why?
| | Leukemia, Myeloid, Acute | 7 | 2020 | 700 | 0.520 |
Why?
| | Anemia | 3 | 2024 | 189 | 0.500 |
Why?
| | Muscle, Skeletal | 9 | 2025 | 1795 | 0.500 |
Why?
| | Bone Marrow | 1 | 2018 | 308 | 0.490 |
Why?
| | Oxidation-Reduction | 11 | 2025 | 1075 | 0.490 |
Why?
| | Myelodysplastic Syndromes | 3 | 2026 | 170 | 0.480 |
Why?
| | Nitrogen | 1 | 2017 | 125 | 0.480 |
Why?
| | Aging | 8 | 2024 | 1983 | 0.480 |
Why?
| | Altitude Sickness | 5 | 2018 | 141 | 0.470 |
Why?
| | Exercise Tolerance | 3 | 2025 | 288 | 0.450 |
Why?
| | Biomarkers | 10 | 2024 | 4329 | 0.440 |
Why?
| | Kynurenine | 5 | 2024 | 114 | 0.440 |
Why?
| | Mice, Inbred C57BL | 18 | 2026 | 6021 | 0.430 |
Why?
| | Inflammation | 7 | 2024 | 2915 | 0.420 |
Why?
| | Male | 54 | 2025 | 73014 | 0.420 |
Why?
| | Exercise | 3 | 2023 | 2206 | 0.410 |
Why?
| | Proteome | 5 | 2025 | 520 | 0.400 |
Why?
| | Mitochondria | 8 | 2025 | 996 | 0.390 |
Why?
| | Adenosine Triphosphate | 3 | 2025 | 494 | 0.390 |
Why?
| | Lipids | 1 | 2019 | 715 | 0.390 |
Why?
| | Taste Buds | 1 | 2015 | 214 | 0.360 |
Why?
| | Female | 52 | 2026 | 79080 | 0.350 |
Why?
| | Neoplastic Stem Cells | 4 | 2021 | 402 | 0.350 |
Why?
| | Healthy Volunteers | 7 | 2021 | 217 | 0.350 |
Why?
| | Chromatography, High Pressure Liquid | 7 | 2019 | 588 | 0.340 |
Why?
| | Extracellular Vesicles | 2 | 2025 | 175 | 0.330 |
Why?
| | Hemorrhage | 2 | 2022 | 824 | 0.330 |
Why?
| | Oxygen | 5 | 2020 | 996 | 0.320 |
Why?
| | Adaptation, Physiological | 4 | 2018 | 567 | 0.300 |
Why?
| | Flavones | 2 | 2019 | 11 | 0.300 |
Why?
| | Adult | 29 | 2025 | 40821 | 0.300 |
Why?
| | Glutathione | 4 | 2025 | 369 | 0.300 |
Why?
| | Drug Resistance, Neoplasm | 3 | 2021 | 889 | 0.300 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 3 | 2020 | 291 | 0.290 |
Why?
| | Sphingosine | 3 | 2023 | 46 | 0.290 |
Why?
| | Altitude | 4 | 2023 | 469 | 0.290 |
Why?
| | Blood Banks | 3 | 2019 | 50 | 0.290 |
Why?
| | Rats, Sprague-Dawley | 8 | 2020 | 2533 | 0.290 |
Why?
| | Lysophospholipids | 3 | 2023 | 80 | 0.280 |
Why?
| | Adenine | 2 | 2025 | 338 | 0.270 |
Why?
| | Neoplasm Proteins | 2 | 2025 | 443 | 0.270 |
Why?
| | Alcohol Oxidoreductases | 2 | 2025 | 61 | 0.270 |
Why?
| | Polyamines | 3 | 2024 | 42 | 0.270 |
Why?
| | Niacinamide | 2 | 2026 | 103 | 0.260 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2025 | 1223 | 0.260 |
Why?
| | Acclimatization | 3 | 2018 | 169 | 0.260 |
Why?
| | Blood Transfusion | 4 | 2024 | 393 | 0.250 |
Why?
| | Cold Temperature | 3 | 2025 | 207 | 0.250 |
Why?
| | Thrombosis | 2 | 2022 | 397 | 0.250 |
Why?
| | RNA-Binding Proteins | 3 | 2023 | 463 | 0.250 |
Why?
| | Arginine | 3 | 2024 | 263 | 0.250 |
Why?
| | fms-Like Tyrosine Kinase 3 | 2 | 2017 | 51 | 0.250 |
Why?
| | Hematopoiesis | 2 | 2018 | 195 | 0.250 |
Why?
| | Larva | 6 | 2025 | 242 | 0.240 |
Why?
| | Mammals | 3 | 2023 | 287 | 0.240 |
Why?
| | Erythrocyte Aging | 2 | 2024 | 12 | 0.240 |
Why?
| | Sciuridae | 2 | 2019 | 152 | 0.240 |
Why?
| | Gene Expression Regulation, Leukemic | 2 | 2016 | 56 | 0.240 |
Why?
| | Plasma | 3 | 2017 | 222 | 0.240 |
Why?
| | Oxygen Consumption | 4 | 2024 | 719 | 0.240 |
Why?
| | Chemokine CXCL13 | 1 | 2026 | 15 | 0.240 |
Why?
| | Cell Line, Tumor | 11 | 2026 | 3538 | 0.230 |
Why?
| | Cysteine | 2 | 2025 | 210 | 0.230 |
Why?
| | Signal Transduction | 9 | 2025 | 5234 | 0.230 |
Why?
| | Isotope Labeling | 2 | 2017 | 81 | 0.230 |
Why?
| | Focal Adhesion Kinase 1 | 1 | 2026 | 32 | 0.230 |
Why?
| | Tryptophan | 4 | 2021 | 183 | 0.230 |
Why?
| | Wolbachia | 1 | 2025 | 3 | 0.230 |
Why?
| | Amino Acids, Branched-Chain | 1 | 2026 | 39 | 0.230 |
Why?
| | Anti-Inflammatory Agents | 2 | 2021 | 473 | 0.230 |
Why?
| | Mice, Knockout | 6 | 2025 | 3121 | 0.230 |
Why?
| | Macrophages, Peritoneal | 1 | 2026 | 89 | 0.230 |
Why?
| | Maternal Nutritional Physiological Phenomena | 2 | 2018 | 178 | 0.230 |
Why?
| | Insulin Resistance | 3 | 2021 | 1247 | 0.230 |
Why?
| | Collagen | 2 | 2020 | 460 | 0.230 |
Why?
| | Drosophila | 2 | 2024 | 168 | 0.230 |
Why?
| | Erythropoiesis | 2 | 2023 | 57 | 0.220 |
Why?
| | Glycerolphosphate Dehydrogenase | 1 | 2025 | 5 | 0.220 |
Why?
| | Qa-SNARE Proteins | 1 | 2025 | 18 | 0.220 |
Why?
| | Rats | 7 | 2021 | 5574 | 0.220 |
Why?
| | Wounds and Injuries | 3 | 2020 | 956 | 0.220 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 387 | 0.220 |
Why?
| | Interleukin-1 | 2 | 2021 | 960 | 0.220 |
Why?
| | Coronavirus Infections | 2 | 2020 | 379 | 0.220 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2025 | 112 | 0.220 |
Why?
| | Polymorphism, Genetic | 2 | 2025 | 611 | 0.220 |
Why?
| | Pentose Phosphate Pathway | 4 | 2018 | 55 | 0.220 |
Why?
| | Caffeine | 1 | 2025 | 76 | 0.220 |
Why?
| | Symbiosis | 1 | 2025 | 71 | 0.220 |
Why?
| | Primaquine | 1 | 2024 | 7 | 0.210 |
Why?
| | GTP Phosphohydrolases | 1 | 2025 | 95 | 0.210 |
Why?
| | Phosphofructokinases | 1 | 2024 | 7 | 0.210 |
Why?
| | Homeodomain Proteins | 2 | 2020 | 525 | 0.210 |
Why?
| | Solute Carrier Family 22 Member 5 | 1 | 2024 | 7 | 0.210 |
Why?
| | Hexokinase | 1 | 2024 | 18 | 0.210 |
Why?
| | Rejuvenation | 1 | 2024 | 18 | 0.210 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2026 | 145 | 0.210 |
Why?
| | Physical Conditioning, Animal | 2 | 2025 | 242 | 0.210 |
Why?
| | Stress, Physiological | 2 | 2025 | 449 | 0.210 |
Why?
| | Triple Negative Breast Neoplasms | 2 | 2018 | 219 | 0.200 |
Why?
| | Cardiorespiratory Fitness | 1 | 2024 | 73 | 0.200 |
Why?
| | Large Neutral Amino Acid-Transporter 1 | 1 | 2024 | 17 | 0.200 |
Why?
| | In Vitro Techniques | 3 | 2021 | 1041 | 0.200 |
Why?
| | Blood Group Antigens | 1 | 2023 | 15 | 0.200 |
Why?
| | Mitochondria, Muscle | 3 | 2021 | 125 | 0.200 |
Why?
| | Rh-Hr Blood-Group System | 1 | 2023 | 15 | 0.200 |
Why?
| | DNA, Mitochondrial | 1 | 2025 | 212 | 0.200 |
Why?
| | Pyruvate Kinase | 1 | 2023 | 29 | 0.200 |
Why?
| | Erythrocyte Deformability | 2 | 2021 | 23 | 0.200 |
Why?
| | Uric Acid | 1 | 2025 | 167 | 0.200 |
Why?
| | Emtricitabine | 1 | 2025 | 209 | 0.200 |
Why?
| | Chromatography, Liquid | 3 | 2025 | 452 | 0.200 |
Why?
| | Epithelial-Mesenchymal Transition | 3 | 2021 | 218 | 0.200 |
Why?
| | Glutamine | 3 | 2019 | 110 | 0.200 |
Why?
| | Isoenzymes | 1 | 2024 | 294 | 0.200 |
Why?
| | Middle Aged | 15 | 2025 | 36359 | 0.200 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 2 | 2021 | 51 | 0.190 |
Why?
| | Satellite Cells, Skeletal Muscle | 1 | 2023 | 35 | 0.190 |
Why?
| | Succinates | 1 | 2023 | 25 | 0.190 |
Why?
| | Cerebral Hemorrhage | 1 | 2024 | 125 | 0.190 |
Why?
| | Lactates | 1 | 2023 | 82 | 0.190 |
Why?
| | Furin | 1 | 2022 | 12 | 0.190 |
Why?
| | Tenofovir | 1 | 2025 | 300 | 0.190 |
Why?
| | Oxidative Phosphorylation | 3 | 2018 | 212 | 0.190 |
Why?
| | Pluripotent Stem Cells | 1 | 2023 | 78 | 0.190 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2024 | 215 | 0.190 |
Why?
| | Down-Regulation | 1 | 2025 | 612 | 0.190 |
Why?
| | 2,3-Diphosphoglycerate | 5 | 2023 | 32 | 0.190 |
Why?
| | Mitochondrial Proteins | 1 | 2025 | 263 | 0.190 |
Why?
| | Streptococcus pneumoniae | 1 | 2025 | 187 | 0.190 |
Why?
| | Autophagy | 1 | 2025 | 290 | 0.190 |
Why?
| | Equidae | 1 | 2022 | 7 | 0.180 |
Why?
| | src-Family Kinases | 1 | 2023 | 93 | 0.180 |
Why?
| | Protein Processing, Post-Translational | 3 | 2025 | 485 | 0.180 |
Why?
| | Histiocytosis | 1 | 2022 | 9 | 0.180 |
Why?
| | Alleles | 1 | 2025 | 900 | 0.180 |
Why?
| | Obesity | 5 | 2021 | 3123 | 0.180 |
Why?
| | Bicycling | 1 | 2023 | 117 | 0.180 |
Why?
| | Liver | 3 | 2019 | 1859 | 0.180 |
Why?
| | AMP-Activated Protein Kinases | 3 | 2022 | 192 | 0.180 |
Why?
| | Glucose | 3 | 2017 | 1051 | 0.180 |
Why?
| | Peptide Hydrolases | 1 | 2022 | 105 | 0.180 |
Why?
| | Erdheim-Chester Disease | 1 | 2021 | 4 | 0.180 |
Why?
| | Neutrophils | 2 | 2025 | 1132 | 0.170 |
Why?
| | Sulfonamides | 3 | 2020 | 592 | 0.170 |
Why?
| | Embryo, Mammalian | 1 | 2022 | 230 | 0.170 |
Why?
| | Cholesterol | 2 | 2022 | 410 | 0.170 |
Why?
| | Asparagine | 2 | 2018 | 34 | 0.170 |
Why?
| | Ranitidine | 1 | 2021 | 14 | 0.170 |
Why?
| | Sphingolipids | 2 | 2021 | 83 | 0.170 |
Why?
| | Erythrocyte Count | 1 | 2021 | 20 | 0.170 |
Why?
| | Lactic Acid | 5 | 2024 | 295 | 0.170 |
Why?
| | Auditory Pathways | 1 | 2021 | 53 | 0.170 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2019 | 193 | 0.170 |
Why?
| | Metabolic Networks and Pathways | 2 | 2019 | 175 | 0.160 |
Why?
| | Protein Domains | 1 | 2022 | 314 | 0.160 |
Why?
| | Stearoyl-CoA Desaturase | 1 | 2021 | 66 | 0.160 |
Why?
| | Fatty Acid Desaturases | 1 | 2021 | 32 | 0.160 |
Why?
| | Metformin | 1 | 2024 | 328 | 0.160 |
Why?
| | Transgender Persons | 1 | 2024 | 213 | 0.160 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 250 | 0.160 |
Why?
| | Syndecan-1 | 1 | 2020 | 42 | 0.160 |
Why?
| | Virulence Factors | 1 | 2022 | 175 | 0.160 |
Why?
| | Resistance Training | 1 | 2023 | 185 | 0.160 |
Why?
| | Benzothiazoles | 2 | 2017 | 39 | 0.160 |
Why?
| | Testosterone | 1 | 2024 | 419 | 0.160 |
Why?
| | Cell Plasticity | 1 | 2021 | 37 | 0.160 |
Why?
| | Cellular Microenvironment | 1 | 2021 | 94 | 0.160 |
Why?
| | Cellular Reprogramming | 2 | 2021 | 98 | 0.160 |
Why?
| | Stromal Cells | 1 | 2020 | 123 | 0.160 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2021 | 128 | 0.160 |
Why?
| | Aged | 8 | 2024 | 26251 | 0.150 |
Why?
| | Small Molecule Libraries | 1 | 2021 | 113 | 0.150 |
Why?
| | Genome-Wide Association Study | 2 | 2024 | 1526 | 0.150 |
Why?
| | Tandem Mass Spectrometry | 3 | 2025 | 574 | 0.150 |
Why?
| | Osmotic Pressure | 1 | 2020 | 41 | 0.150 |
Why?
| | Macrophage Activation | 1 | 2021 | 182 | 0.150 |
Why?
| | Phosphatidylserines | 1 | 2020 | 62 | 0.150 |
Why?
| | TCF Transcription Factors | 1 | 2019 | 19 | 0.150 |
Why?
| | Cannabinoids | 1 | 2022 | 181 | 0.150 |
Why?
| | Taurine | 1 | 2020 | 41 | 0.150 |
Why?
| | Cannabidiol | 1 | 2022 | 142 | 0.150 |
Why?
| | Topoisomerase II Inhibitors | 1 | 2019 | 24 | 0.150 |
Why?
| | Time Factors | 10 | 2024 | 7079 | 0.150 |
Why?
| | Phenylurea Compounds | 2 | 2017 | 122 | 0.150 |
Why?
| | Ovarian Neoplasms | 1 | 2026 | 598 | 0.150 |
Why?
| | Shock | 1 | 2020 | 99 | 0.150 |
Why?
| | Transcription Factors | 2 | 2025 | 1728 | 0.150 |
Why?
| | Macrophages | 4 | 2022 | 1530 | 0.150 |
Why?
| | Parabiosis | 1 | 2019 | 11 | 0.150 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2021 | 230 | 0.150 |
Why?
| | Hibernation | 2 | 2019 | 82 | 0.150 |
Why?
| | STAT3 Transcription Factor | 1 | 2021 | 214 | 0.150 |
Why?
| | Tryptophan Oxygenase | 2 | 2018 | 33 | 0.150 |
Why?
| | Hydrogen Peroxide | 1 | 2021 | 337 | 0.150 |
Why?
| | Torpor | 1 | 2019 | 19 | 0.140 |
Why?
| | Cell Proliferation | 6 | 2026 | 2497 | 0.140 |
Why?
| | Circadian Clocks | 1 | 2019 | 59 | 0.140 |
Why?
| | Quantitative Trait Loci | 3 | 2025 | 388 | 0.140 |
Why?
| | Thyroid Neoplasms | 1 | 2023 | 380 | 0.140 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2025 | 929 | 0.140 |
Why?
| | Cigarette Smoking | 1 | 2020 | 103 | 0.140 |
Why?
| | Hydrogen-Ion Concentration | 3 | 2024 | 533 | 0.140 |
Why?
| | Homeostasis | 2 | 2022 | 646 | 0.140 |
Why?
| | Aspartic Acid | 1 | 2018 | 88 | 0.140 |
Why?
| | Gene-Environment Interaction | 1 | 2020 | 188 | 0.140 |
Why?
| | Blood Specimen Collection | 1 | 2018 | 37 | 0.140 |
Why?
| | Adenosine | 2 | 2017 | 255 | 0.140 |
Why?
| | Machine Learning | 2 | 2021 | 590 | 0.140 |
Why?
| | Arousal | 1 | 2019 | 157 | 0.140 |
Why?
| | Hypertension, Pulmonary | 2 | 2021 | 1957 | 0.140 |
Why?
| | Renal Insufficiency | 1 | 2020 | 172 | 0.140 |
Why?
| | Bile Acids and Salts | 1 | 2019 | 162 | 0.140 |
Why?
| | Anemia, Sickle Cell | 2 | 2024 | 322 | 0.140 |
Why?
| | Stem Cell Niche | 1 | 2018 | 57 | 0.130 |
Why?
| | Deamination | 1 | 2017 | 6 | 0.130 |
Why?
| | Proteostasis | 1 | 2018 | 32 | 0.130 |
Why?
| | Erythrocytes, Abnormal | 1 | 2017 | 14 | 0.130 |
Why?
| | Vascular Diseases | 1 | 2020 | 251 | 0.130 |
Why?
| | Hemoglobin A | 1 | 2017 | 21 | 0.130 |
Why?
| | Hemoglobin, Sickle | 1 | 2017 | 20 | 0.130 |
Why?
| | Benzeneacetamides | 1 | 2017 | 8 | 0.130 |
Why?
| | Macrophages, Alveolar | 1 | 2021 | 377 | 0.130 |
Why?
| | Glutaminase | 1 | 2017 | 11 | 0.130 |
Why?
| | Diglycerides | 1 | 2018 | 66 | 0.130 |
Why?
| | Cryopreservation | 1 | 2018 | 115 | 0.130 |
Why?
| | Transcriptome | 2 | 2021 | 1066 | 0.130 |
Why?
| | Disease Models, Animal | 7 | 2025 | 4565 | 0.130 |
Why?
| | Thiadiazoles | 1 | 2017 | 25 | 0.130 |
Why?
| | Calcium | 2 | 2022 | 1181 | 0.130 |
Why?
| | Nicotine | 1 | 2020 | 334 | 0.130 |
Why?
| | Anti-HIV Agents | 1 | 2025 | 914 | 0.130 |
Why?
| | Folic Acid Deficiency | 1 | 2017 | 49 | 0.130 |
Why?
| | Immune System | 1 | 2018 | 181 | 0.130 |
Why?
| | Equilibrative Nucleoside Transporter 1 | 1 | 2017 | 19 | 0.130 |
Why?
| | Limit of Detection | 1 | 2017 | 92 | 0.120 |
Why?
| | Basigin | 1 | 2017 | 24 | 0.120 |
Why?
| | Resuscitation | 2 | 2018 | 314 | 0.120 |
Why?
| | Body Fluids | 1 | 2017 | 70 | 0.120 |
Why?
| | Tumor Microenvironment | 2 | 2018 | 745 | 0.120 |
Why?
| | Mutation | 6 | 2025 | 4082 | 0.120 |
Why?
| | Citric Acid | 1 | 2016 | 33 | 0.120 |
Why?
| | Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2016 | 6 | 0.120 |
Why?
| | Nitriles | 1 | 2018 | 211 | 0.120 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 167 | 0.120 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 2016 | 69 | 0.120 |
Why?
| | Bacteria | 1 | 2022 | 766 | 0.120 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2024 | 2228 | 0.120 |
Why?
| | Inflammasomes | 1 | 2018 | 145 | 0.120 |
Why?
| | Young Adult | 8 | 2021 | 14240 | 0.120 |
Why?
| | Saline Solution, Hypertonic | 1 | 2016 | 43 | 0.120 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2018 | 314 | 0.120 |
Why?
| | Gene Expression Regulation, Developmental | 4 | 2025 | 899 | 0.120 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 104 | 0.120 |
Why?
| | Interleukin-6 | 1 | 2020 | 782 | 0.120 |
Why?
| | Folic Acid | 1 | 2017 | 197 | 0.120 |
Why?
| | Diethylhexyl Phthalate | 1 | 2015 | 13 | 0.120 |
Why?
| | Models, Biological | 2 | 2021 | 1758 | 0.120 |
Why?
| | Breast Neoplasms | 2 | 2020 | 2411 | 0.110 |
Why?
| | Phosphatidylethanolamines | 1 | 2016 | 78 | 0.110 |
Why?
| | Reperfusion Injury | 1 | 2018 | 300 | 0.110 |
Why?
| | Antioxidants | 1 | 2019 | 544 | 0.110 |
Why?
| | Brain Death | 1 | 2016 | 58 | 0.110 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2016 | 96 | 0.110 |
Why?
| | Neoplasms | 2 | 2022 | 2944 | 0.110 |
Why?
| | Reactive Oxygen Species | 4 | 2022 | 610 | 0.110 |
Why?
| | Membrane Transport Proteins | 1 | 2017 | 153 | 0.110 |
Why?
| | Metabolic Flux Analysis | 1 | 2015 | 8 | 0.110 |
Why?
| | Biochemistry | 1 | 2015 | 36 | 0.110 |
Why?
| | Anoikis | 1 | 2015 | 30 | 0.110 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 265 | 0.110 |
Why?
| | Hydroxylysine | 1 | 2015 | 4 | 0.110 |
Why?
| | Acidosis | 1 | 2016 | 105 | 0.110 |
Why?
| | Phosphatidylcholines | 1 | 2016 | 130 | 0.110 |
Why?
| | Vasodilation | 1 | 2018 | 519 | 0.110 |
Why?
| | Glutarates | 2 | 2025 | 11 | 0.110 |
Why?
| | Bronchoalveolar Lavage | 1 | 2015 | 90 | 0.110 |
Why?
| | Fluid Therapy | 1 | 2016 | 152 | 0.110 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2015 | 61 | 0.110 |
Why?
| | Blood Volume | 1 | 2015 | 57 | 0.110 |
Why?
| | Pandemics | 2 | 2020 | 1700 | 0.110 |
Why?
| | Cognitive Dysfunction | 1 | 2021 | 479 | 0.110 |
Why?
| | Citrates | 1 | 2014 | 41 | 0.110 |
Why?
| | Immunity, Innate | 1 | 2021 | 843 | 0.110 |
Why?
| | Platelet Transfusion | 1 | 2015 | 76 | 0.110 |
Why?
| | Mice, Transgenic | 4 | 2025 | 2131 | 0.110 |
Why?
| | Cytoskeletal Proteins | 1 | 2015 | 146 | 0.110 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2021 | 639 | 0.110 |
Why?
| | Cells, Cultured | 5 | 2021 | 4112 | 0.110 |
Why?
| | Sulfur | 3 | 2022 | 60 | 0.110 |
Why?
| | Organ Preservation Solutions | 1 | 2014 | 46 | 0.110 |
Why?
| | Extinction, Biological | 1 | 2015 | 34 | 0.110 |
Why?
| | Linear Models | 1 | 2017 | 847 | 0.110 |
Why?
| | Brain Injuries, Traumatic | 1 | 2021 | 459 | 0.110 |
Why?
| | Amyloid beta-Peptides | 1 | 2017 | 251 | 0.110 |
Why?
| | Adipose Tissue | 2 | 2017 | 641 | 0.100 |
Why?
| | Reproducibility of Results | 2 | 2026 | 3396 | 0.100 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2017 | 641 | 0.100 |
Why?
| | Health Status | 1 | 2019 | 822 | 0.100 |
Why?
| | Sodium Chloride | 1 | 2014 | 138 | 0.100 |
Why?
| | Endothelium, Vascular | 1 | 2020 | 952 | 0.100 |
Why?
| | Phosphates | 1 | 2014 | 175 | 0.100 |
Why?
| | Methionine | 3 | 2020 | 160 | 0.100 |
Why?
| | Proteolysis | 3 | 2020 | 174 | 0.100 |
Why?
| | Peptide Fragments | 1 | 2017 | 693 | 0.100 |
Why?
| | Fetal Development | 1 | 2016 | 296 | 0.100 |
Why?
| | Heart Ventricles | 1 | 2018 | 762 | 0.100 |
Why?
| | Dietary Supplements | 1 | 2017 | 586 | 0.100 |
Why?
| | Glucose Tolerance Test | 3 | 2021 | 360 | 0.090 |
Why?
| | Antineoplastic Agents | 3 | 2019 | 2218 | 0.090 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2023 | 2623 | 0.090 |
Why?
| | Muscles | 2 | 2023 | 330 | 0.090 |
Why?
| | Prognosis | 1 | 2021 | 4331 | 0.090 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2016 | 530 | 0.090 |
Why?
| | Diet | 1 | 2020 | 1271 | 0.090 |
Why?
| | Nuclear Proteins | 1 | 2017 | 739 | 0.090 |
Why?
| | MicroRNAs | 1 | 2018 | 695 | 0.090 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2018 | 662 | 0.090 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 2 | 2025 | 15 | 0.090 |
Why?
| | Nerve Tissue Proteins | 1 | 2015 | 594 | 0.090 |
Why?
| | Colorectal Neoplasms | 1 | 2019 | 870 | 0.080 |
Why?
| | Microbiota | 1 | 2018 | 724 | 0.080 |
Why?
| | Mice, Inbred NOD | 3 | 2017 | 598 | 0.080 |
Why?
| | Xenograft Model Antitumor Assays | 3 | 2019 | 928 | 0.080 |
Why?
| | Liver Neoplasms | 1 | 2016 | 774 | 0.080 |
Why?
| | Cytokines | 3 | 2026 | 2079 | 0.080 |
Why?
| | Epithelial Cells | 1 | 2016 | 1118 | 0.080 |
Why?
| | Cell Line | 3 | 2022 | 2809 | 0.080 |
Why?
| | Citric Acid Cycle | 2 | 2021 | 58 | 0.080 |
Why?
| | Protein Kinase Inhibitors | 3 | 2023 | 982 | 0.080 |
Why?
| | Bisphosphoglycerate Mutase | 2 | 2021 | 7 | 0.070 |
Why?
| | HIV Infections | 1 | 2025 | 3210 | 0.070 |
Why?
| | Cattle | 2 | 2022 | 938 | 0.070 |
Why?
| | Insulin | 2 | 2021 | 2524 | 0.070 |
Why?
| | Phenotype | 4 | 2020 | 3186 | 0.070 |
Why?
| | Glucose Clamp Technique | 2 | 2021 | 199 | 0.070 |
Why?
| | Phosphorylation | 3 | 2018 | 1717 | 0.070 |
Why?
| | Pancreatic Neoplasms | 1 | 2017 | 944 | 0.070 |
Why?
| | Fatty Acids, Nonesterified | 2 | 2020 | 154 | 0.070 |
Why?
| | Diet, High-Fat | 2 | 2019 | 267 | 0.070 |
Why?
| | Macaca | 2 | 2018 | 66 | 0.070 |
Why?
| | Adolescent | 3 | 2024 | 22451 | 0.060 |
Why?
| | Enzyme Activation | 2 | 2021 | 758 | 0.060 |
Why?
| | Betacoronavirus | 2 | 2020 | 288 | 0.060 |
Why?
| | Brain | 2 | 2021 | 2981 | 0.060 |
Why?
| | Microscopy, Electron, Scanning | 2 | 2018 | 193 | 0.060 |
Why?
| | Apoptosis | 3 | 2021 | 2436 | 0.060 |
Why?
| | Bacterial Proteins | 2 | 2025 | 976 | 0.060 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2018 | 1429 | 0.060 |
Why?
| | Nicotinamide Phosphoribosyltransferase | 1 | 2026 | 26 | 0.060 |
Why?
| | Sex Characteristics | 2 | 2023 | 798 | 0.060 |
Why?
| | 5'-Nucleotidase | 2 | 2017 | 49 | 0.060 |
Why?
| | GPI-Linked Proteins | 2 | 2017 | 81 | 0.060 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 1996 | 0.060 |
Why?
| | Epigenesis, Genetic | 2 | 2021 | 705 | 0.060 |
Why?
| | Cell Adhesion | 2 | 2018 | 447 | 0.060 |
Why?
| | Molecular Targeted Therapy | 2 | 2019 | 446 | 0.060 |
Why?
| | Mice, Nude | 2 | 2018 | 665 | 0.060 |
Why?
| | Neurons | 1 | 2015 | 1663 | 0.060 |
Why?
| | Pupa | 1 | 2025 | 14 | 0.060 |
Why?
| | Biopsy | 2 | 2020 | 1073 | 0.060 |
Why?
| | Isotonic Solutions | 2 | 2016 | 43 | 0.060 |
Why?
| | Swine | 2 | 2018 | 821 | 0.060 |
Why?
| | Mitochondrial Membrane Transport Proteins | 1 | 2025 | 46 | 0.050 |
Why?
| | Isocitrate Dehydrogenase | 1 | 2025 | 71 | 0.050 |
Why?
| | Glucose Transport Proteins, Facilitative | 1 | 2025 | 16 | 0.050 |
Why?
| | Carbohydrate Metabolism | 1 | 2025 | 59 | 0.050 |
Why?
| | Exosomes | 1 | 2026 | 103 | 0.050 |
Why?
| | Mitochondrial Dynamics | 1 | 2025 | 41 | 0.050 |
Why?
| | Plateletpheresis | 1 | 2024 | 28 | 0.050 |
Why?
| | Deferoxamine | 1 | 2024 | 27 | 0.050 |
Why?
| | Cell Survival | 2 | 2019 | 1102 | 0.050 |
Why?
| | Antimalarials | 1 | 2024 | 35 | 0.050 |
Why?
| | Lipid Peroxidation | 1 | 2025 | 168 | 0.050 |
Why?
| | RNA Interference | 2 | 2017 | 470 | 0.050 |
Why?
| | Cell Division | 1 | 2026 | 735 | 0.050 |
Why?
| | Indoleacetic Acids | 1 | 2024 | 10 | 0.050 |
Why?
| | Alanine | 1 | 2025 | 171 | 0.050 |
Why?
| | Pyruvates | 1 | 2023 | 23 | 0.050 |
Why?
| | Cell Lineage | 1 | 2026 | 375 | 0.050 |
Why?
| | Pneumococcal Infections | 1 | 2025 | 104 | 0.050 |
Why?
| | Organophosphates | 1 | 2025 | 179 | 0.050 |
Why?
| | Lipopolysaccharides | 2 | 2018 | 861 | 0.050 |
Why?
| | Respiratory Therapy | 1 | 2023 | 25 | 0.050 |
Why?
| | Blood Glucose | 3 | 2020 | 2357 | 0.050 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2024 | 96 | 0.050 |
Why?
| | RNA, Small Interfering | 2 | 2016 | 630 | 0.050 |
Why?
| | Doxorubicin | 1 | 2026 | 414 | 0.050 |
Why?
| | CRISPR-Cas Systems | 1 | 2025 | 163 | 0.050 |
Why?
| | Pantothenic Acid | 1 | 2023 | 5 | 0.050 |
Why?
| | Endothelial Cells | 2 | 2020 | 876 | 0.050 |
Why?
| | Africa South of the Sahara | 1 | 2023 | 56 | 0.050 |
Why?
| | Puberty | 1 | 2024 | 141 | 0.050 |
Why?
| | Myeloid Cells | 1 | 2024 | 149 | 0.050 |
Why?
| | Acyl Coenzyme A | 1 | 2023 | 32 | 0.050 |
Why?
| | Dasatinib | 1 | 2023 | 58 | 0.050 |
Why?
| | Prospective Studies | 3 | 2021 | 8087 | 0.050 |
Why?
| | Cell Cycle | 1 | 2026 | 595 | 0.050 |
Why?
| | Iodine Radioisotopes | 1 | 2023 | 139 | 0.050 |
Why?
| | RNA Splicing Factors | 1 | 2023 | 66 | 0.050 |
Why?
| | Hand Strength | 1 | 2023 | 145 | 0.050 |
Why?
| | Heme | 1 | 2023 | 90 | 0.050 |
Why?
| | Pyrimidinones | 1 | 2023 | 124 | 0.050 |
Why?
| | Leukocytes, Mononuclear | 1 | 2025 | 585 | 0.040 |
Why?
| | Cellular Senescence | 1 | 2024 | 225 | 0.040 |
Why?
| | Adipocytes | 1 | 2023 | 223 | 0.040 |
Why?
| | Gram-Negative Bacteria | 1 | 2022 | 80 | 0.040 |
Why?
| | Thrombin | 1 | 2022 | 174 | 0.040 |
Why?
| | Cell Movement | 2 | 2017 | 950 | 0.040 |
Why?
| | Pyridones | 1 | 2023 | 210 | 0.040 |
Why?
| | Horses | 1 | 2022 | 229 | 0.040 |
Why?
| | Subcellular Fractions | 1 | 2021 | 73 | 0.040 |
Why?
| | Oncogenes | 1 | 2021 | 113 | 0.040 |
Why?
| | Pyruvic Acid | 1 | 2021 | 51 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2022 | 2783 | 0.040 |
Why?
| | Culture Media, Conditioned | 1 | 2021 | 112 | 0.040 |
Why?
| | Protein-Lysine 6-Oxidase | 1 | 2020 | 14 | 0.040 |
Why?
| | Candidiasis | 1 | 2021 | 64 | 0.040 |
Why?
| | Blood Coagulation | 1 | 2022 | 267 | 0.040 |
Why?
| | Immunity | 1 | 2021 | 140 | 0.040 |
Why?
| | Phosphoproteins | 1 | 2023 | 319 | 0.040 |
Why?
| | Cochlea | 1 | 2021 | 63 | 0.040 |
Why?
| | Dogs | 1 | 2022 | 516 | 0.040 |
Why?
| | Point Mutation | 1 | 2021 | 232 | 0.040 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2021 | 97 | 0.040 |
Why?
| | Cystine | 1 | 2020 | 17 | 0.040 |
Why?
| | Muscle Strength | 1 | 2023 | 332 | 0.040 |
Why?
| | Coculture Techniques | 1 | 2021 | 244 | 0.040 |
Why?
| | Cohort Studies | 2 | 2021 | 6045 | 0.040 |
Why?
| | Genome | 1 | 2022 | 307 | 0.040 |
Why?
| | Fat Body | 1 | 2020 | 9 | 0.040 |
Why?
| | Creatine | 1 | 2020 | 63 | 0.040 |
Why?
| | Longevity | 1 | 2021 | 179 | 0.040 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2019 | 3 | 0.040 |
Why?
| | Poly-ADP-Ribose Binding Proteins | 1 | 2019 | 35 | 0.040 |
Why?
| | Phylogeny | 1 | 2023 | 921 | 0.040 |
Why?
| | DNA Topoisomerases, Type II | 1 | 2019 | 42 | 0.040 |
Why?
| | Gene Deletion | 1 | 2021 | 384 | 0.040 |
Why?
| | Electron Transport Chain Complex Proteins | 1 | 2019 | 20 | 0.040 |
Why?
| | Quality of Life | 2 | 2023 | 3187 | 0.040 |
Why?
| | Binding, Competitive | 1 | 2019 | 185 | 0.040 |
Why?
| | Megakaryocytes | 1 | 2019 | 34 | 0.040 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2019 | 194 | 0.040 |
Why?
| | Dietary Carbohydrates | 1 | 2020 | 145 | 0.040 |
Why?
| | Cryoprotective Agents | 1 | 2018 | 11 | 0.040 |
Why?
| | Osmotic Fragility | 1 | 2018 | 12 | 0.040 |
Why?
| | Macaca mulatta | 1 | 2019 | 187 | 0.040 |
Why?
| | Erythrocyte Indices | 1 | 2018 | 33 | 0.040 |
Why?
| | Transplantation, Autologous | 1 | 2020 | 303 | 0.040 |
Why?
| | Platelet Activation | 1 | 2019 | 99 | 0.040 |
Why?
| | Interleukin-3 Receptor alpha Subunit | 1 | 2018 | 17 | 0.040 |
Why?
| | Succinic Acid | 1 | 2018 | 46 | 0.040 |
Why?
| | Sex Factors | 1 | 2025 | 2101 | 0.040 |
Why?
| | Drug Design | 1 | 2019 | 179 | 0.030 |
Why?
| | Glycerol | 1 | 2018 | 90 | 0.030 |
Why?
| | Transplantation, Heterologous | 1 | 2018 | 165 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2023 | 2064 | 0.030 |
Why?
| | Microglia | 1 | 2021 | 285 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2019 | 561 | 0.030 |
Why?
| | Acute Disease | 1 | 2021 | 1033 | 0.030 |
Why?
| | Creatinine | 1 | 2020 | 511 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2021 | 507 | 0.030 |
Why?
| | Purine Nucleotides | 1 | 2018 | 12 | 0.030 |
Why?
| | Gluconeogenesis | 1 | 2018 | 81 | 0.030 |
Why?
| | Sarcolemma | 1 | 2018 | 33 | 0.030 |
Why?
| | Methylation | 1 | 2018 | 241 | 0.030 |
Why?
| | Diet, Western | 1 | 2018 | 88 | 0.030 |
Why?
| | Feeding Behavior | 1 | 2024 | 691 | 0.030 |
Why?
| | Liquid-Liquid Extraction | 1 | 2017 | 13 | 0.030 |
Why?
| | Formic Acid Esters | 1 | 2017 | 3 | 0.030 |
Why?
| | Gene Expression Regulation | 2 | 2017 | 2591 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2021 | 366 | 0.030 |
Why?
| | Crush Injuries | 1 | 2017 | 14 | 0.030 |
Why?
| | Metabolism | 1 | 2017 | 44 | 0.030 |
Why?
| | Swine, Miniature | 1 | 2017 | 88 | 0.030 |
Why?
| | DNA-Binding Proteins | 1 | 2025 | 1467 | 0.030 |
Why?
| | Biological Transport | 1 | 2018 | 423 | 0.030 |
Why?
| | Caspase 1 | 1 | 2018 | 145 | 0.030 |
Why?
| | Azacitidine | 1 | 2018 | 168 | 0.030 |
Why?
| | Precursor Cells, B-Lymphoid | 1 | 2017 | 41 | 0.030 |
Why?
| | Blood Proteins | 1 | 2019 | 239 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2018 | 237 | 0.030 |
Why?
| | Rotarod Performance Test | 1 | 2017 | 15 | 0.030 |
Why?
| | Pyrroles | 1 | 2018 | 221 | 0.030 |
Why?
| | Fluorenes | 1 | 2017 | 45 | 0.030 |
Why?
| | Cytosol | 1 | 2018 | 215 | 0.030 |
Why?
| | Sulfones | 1 | 2018 | 127 | 0.030 |
Why?
| | Cross-Sectional Studies | 2 | 2020 | 5875 | 0.030 |
Why?
| | Monocarboxylic Acid Transporters | 1 | 2017 | 21 | 0.030 |
Why?
| | Plasma Membrane Calcium-Transporting ATPases | 1 | 2017 | 10 | 0.030 |
Why?
| | Random Allocation | 1 | 2018 | 365 | 0.030 |
Why?
| | Prevalence | 1 | 2024 | 2852 | 0.030 |
Why?
| | Gene Expression | 1 | 2022 | 1461 | 0.030 |
Why?
| | Cystathionine | 1 | 2016 | 22 | 0.030 |
Why?
| | Anaerobiosis | 1 | 2017 | 65 | 0.030 |
Why?
| | Periodicity | 1 | 2016 | 57 | 0.030 |
Why?
| | Cell Respiration | 1 | 2017 | 104 | 0.030 |
Why?
| | Nucleotides | 1 | 2017 | 128 | 0.030 |
Why?
| | Weaning | 1 | 2016 | 50 | 0.030 |
Why?
| | Femoral Fractures | 1 | 2017 | 84 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2024 | 3005 | 0.030 |
Why?
| | Quality Control | 1 | 2017 | 162 | 0.030 |
Why?
| | Proteins | 1 | 2022 | 1021 | 0.030 |
Why?
| | NADP | 1 | 2016 | 52 | 0.030 |
Why?
| | Interleukin-18 | 1 | 2018 | 234 | 0.030 |
Why?
| | Hydrazines | 1 | 2016 | 37 | 0.030 |
Why?
| | Protein Folding | 1 | 2018 | 281 | 0.030 |
Why?
| | Ubiquitination | 1 | 2017 | 119 | 0.030 |
Why?
| | Kidney | 1 | 2024 | 1491 | 0.030 |
Why?
| | Bronchioles | 1 | 2016 | 29 | 0.030 |
Why?
| | Hydrogen Sulfide | 1 | 2016 | 47 | 0.030 |
Why?
| | Myoblasts | 1 | 2017 | 83 | 0.030 |
Why?
| | Sesquiterpenes | 1 | 2016 | 51 | 0.030 |
Why?
| | Discriminant Analysis | 1 | 2016 | 35 | 0.030 |
Why?
| | Deoxyglucose | 1 | 2016 | 51 | 0.030 |
Why?
| | Least-Squares Analysis | 1 | 2016 | 73 | 0.030 |
Why?
| | Muscle Proteins | 1 | 2018 | 242 | 0.030 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2017 | 125 | 0.030 |
Why?
| | Triglycerides | 1 | 2018 | 527 | 0.030 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2016 | 81 | 0.030 |
Why?
| | Receptors, Interleukin-1 | 1 | 2017 | 211 | 0.030 |
Why?
| | Cell Cycle Checkpoints | 1 | 2016 | 97 | 0.030 |
Why?
| | Mice, Mutant Strains | 1 | 2016 | 290 | 0.030 |
Why?
| | Stem Cells | 1 | 2020 | 612 | 0.030 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2017 | 155 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2018 | 1293 | 0.030 |
Why?
| | Neurodegenerative Diseases | 1 | 2018 | 147 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2017 | 266 | 0.030 |
Why?
| | Hemodynamics | 1 | 2021 | 1114 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2018 | 394 | 0.030 |
Why?
| | Body Temperature | 1 | 2016 | 227 | 0.030 |
Why?
| | Endoplasmic Reticulum | 1 | 2018 | 268 | 0.030 |
Why?
| | Tumor Burden | 1 | 2017 | 326 | 0.030 |
Why?
| | Bison | 1 | 2015 | 4 | 0.030 |
Why?
| | Recovery of Function | 1 | 2020 | 721 | 0.030 |
Why?
| | Models, Molecular | 1 | 2020 | 1571 | 0.030 |
Why?
| | Crosses, Genetic | 1 | 2015 | 120 | 0.030 |
Why?
| | Glutamic Acid | 1 | 2017 | 255 | 0.030 |
Why?
| | Fibroblasts | 1 | 2021 | 1033 | 0.030 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2015 | 124 | 0.030 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2016 | 214 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1531 | 0.030 |
Why?
| | Body Size | 1 | 2015 | 91 | 0.030 |
Why?
| | Calcium Signaling | 1 | 2017 | 246 | 0.030 |
Why?
| | Sirolimus | 1 | 2016 | 282 | 0.030 |
Why?
| | Glycosylation | 1 | 2015 | 175 | 0.030 |
Why?
| | Mice, SCID | 1 | 2015 | 360 | 0.030 |
Why?
| | Europe | 1 | 2015 | 420 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2016 | 494 | 0.030 |
Why?
| | Transfection | 1 | 2017 | 914 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2018 | 1160 | 0.030 |
Why?
| | Indoles | 1 | 2018 | 509 | 0.030 |
Why?
| | Intestines | 1 | 2017 | 351 | 0.030 |
Why?
| | Pregnancy | 2 | 2018 | 7217 | 0.030 |
Why?
| | Lysine | 1 | 2016 | 302 | 0.030 |
Why?
| | Running | 1 | 2017 | 234 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2020 | 1130 | 0.030 |
Why?
| | Hyperglycemia | 1 | 2018 | 381 | 0.030 |
Why?
| | Seasons | 1 | 2016 | 535 | 0.030 |
Why?
| | Regression Analysis | 1 | 2016 | 994 | 0.030 |
Why?
| | Biomedical Research | 1 | 2020 | 724 | 0.030 |
Why?
| | Skull | 1 | 2015 | 162 | 0.030 |
Why?
| | Exercise Test | 1 | 2017 | 634 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2015 | 503 | 0.020 |
Why?
| | Postpartum Period | 1 | 2016 | 377 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2016 | 1034 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2017 | 1361 | 0.020 |
Why?
| | Up-Regulation | 1 | 2016 | 840 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2910 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2019 | 1429 | 0.020 |
Why?
| | Survival Analysis | 1 | 2016 | 1372 | 0.020 |
Why?
| | Acute Lung Injury | 1 | 2016 | 311 | 0.020 |
Why?
| | Sequence Analysis, RNA | 1 | 2015 | 441 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2015 | 693 | 0.020 |
Why?
| | Body Mass Index | 1 | 2021 | 2446 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2020 | 3633 | 0.020 |
Why?
| | Athletes | 1 | 2016 | 430 | 0.020 |
Why?
| | Fetus | 1 | 2016 | 798 | 0.020 |
Why?
| | NF-kappa B | 1 | 2015 | 674 | 0.020 |
Why?
| | Gastrointestinal Microbiome | 1 | 2019 | 767 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 2088 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2835 | 0.020 |
Why?
| | Protein Binding | 1 | 2017 | 2239 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2024 | 11744 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2019 | 8351 | 0.020 |
Why?
| | United States | 1 | 2015 | 16041 | 0.010 |
Why?
|
|
Nemkov's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|